We are live on ! Find out more
CP

Catalys Pacific Portfolio holdings

AUM $229M
1-Year Est. Return 100.3%
This Fund
S&P 500
This Quarter Est. Return
+41.53%
1 Year Est. Return
+100.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$148M
AUM Growth
+$41.5M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLYS icon
1
Mineralys Therapeutics
MLYS
$2.34B
$119M 80.13%
9,194,579
HLVX
2
DELISTED
HilleVax
HLVX
$21.8M 14.69%
1,308,974
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$679M
$7.67M 5.18%
721,962

Similar funds

Catalys Pacific's Q1 2024 Portfolio in Review

As of Q1 2024, Catalys Pacific held 3 positions worth $148M, up 39% from $107M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 0%. Catalys Pacific opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Catalys Pacific's ten largest holdings make up 100% of its $148M portfolio in Q1 2024.
  • Catalys Pacific opened 0 new positions and closed 0 in Q1 2024.
  • Catalys Pacific's portfolio value rose 39% quarter-over-quarter to $148M.

Based on Catalys Pacific's 13F filing for Q1 2024, filed 14 May 2024.